Disc Medicine, Inc. (IRON)
55.74
-0.86
(-1.52%)
USD |
NASDAQ |
Oct 14, 16:00
55.68
-0.06
(-0.11%)
Pre-Market: 20:00
Disc Medicine Total Liabilities (Quarterly) : 90.91M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 90.91M |
| March 31, 2026 | 61.78M |
| December 31, 2025 | 67.05M |
| September 30, 2025 | 57.06M |
| June 30, 2025 | 50.90M |
| March 31, 2025 | 48.90M |
| December 31, 2024 | 53.19M |
| September 30, 2024 | 27.18M |
| June 30, 2024 | 21.39M |
| March 31, 2024 | 16.11M |
| December 31, 2023 | 22.88M |
| September 30, 2023 | 17.52M |
| June 30, 2023 | 12.96M |
| Date | Value |
|---|---|
| March 31, 2023 | 10.92M |
| December 31, 2022 | 23.60M |
| September 30, 2022 | 1.464M |
| June 30, 2022 | 6.436M |
| March 31, 2022 | 12.67M |
| December 31, 2021 | 14.76M |
| September 30, 2021 | 14.67M |
| June 30, 2021 | 14.74M |
| March 31, 2021 | 18.22M |
| December 31, 2020 | 30.18M |
| September 30, 2020 | 4.779M |
| June 30, 2020 | 0.0545M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 297.66M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 735.07M |
| Shareholders Equity (Quarterly) | 644.16M |
| Debt to Equity Ratio | 0.0945 |
| Current Ratio | 24.14 |
| Net Debt Paydown Yield | -0.22% |